Picture of Oriola Oyj logo

ORIOLA — Oriola Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedSmall CapContrarian

Brief: Oriola Q3 Adjusted Operating Profit Down At EUR 9.8 Mln

Oct 25 (Reuters) - Oriola Oyj  OKDBV.HE :
    * ORIOLA CORPORATION'S INTERIM REPORT 1
JANUARY-30 SEPTEMBER 2019
    * Q3 NET SALES EUR 429.0 MILLION VERSUS EUR 369.9 MILLION
YEAR AGO
    * Q3 ADJUSTED OPERATING PROFIT EUR 9.8 MILLION VERSUS EUR
17.5
MILLION YEAR AGO
    * BUSINESS OUTLOOK WAS CHANGED ON 19 JUNE 2019, AND ADJUSTED
EBIT
IS ESTIMATED TO DECREASE FROM 2018 LEVEL.
    * ONLINE SALES GREW BY 33% AND ESPECIALLY SALES OF
PRESCRIPTION
MEDICINES WAS INCREASING
    * PHARMA CONTINUED STRONG GROWTH IN BOTH OPERATING COUNTRIES
    * ORIOLA'S STRATEGIC PROGRAMMES, 20BY20 EXCELLENCE AND
CUSTOMER
EXPERIENCE, ARE PROGRESSING ACCORDING TO PLAN

Source text for Eikon:  ID:nWkr5x1SXn 
Further company coverage:  OKDBV.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Oriola Oyj

See all news